Park Medi World Limited (NSE:PARKHOSPS) disclosed on 26 August 2026, under Regulation 30 of SEBI's Listing Regulations, that it has been awarded a Public-Private Partnership mandate by the Prayagraj Municipal Corporation to develop and operate a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh, at an investment of approximately INR 200 crore.
Key Highlights
- The Prayagraj Municipal Corporation has awarded Park Medi World a 45-year long-term lease concession under the PPP model to build and operate a 550-bed multi-super-speciality hospital.
- Park Group will invest approximately INR 200 crore in construction, with INR 76.52 crore reimbursed by the Municipal Corporation, covering around 38% of the capital outlay.
- The facility is to be constructed over two years from the appointed date on a 3.22-acre site, with an option for an additional 2.47 acres from the fifth year after the Commercial Operations Date.
- Park Group will pay an annual concession fee of INR 18.10 crore, subject to 3% annual escalation, and plans to fund its share of investment through internal accruals.
About the Company
Park Medi World Limited (NSE:PARKHOSPS, BSE:544645), headquartered in North India, operates 17 hospitals with a combined capacity of approximately 4,300 beds across 15 cities including Delhi, Gurgaon, Agra, Jaipur, and Patiala. The company offers clinical services across cardiology, neurology, oncology, orthopaedics, nephrology, and organ transplants, positioning itself as North India's second-largest hospital chain.
Announcement in Detail
Under the concession agreement with the Prayagraj Municipal Corporation, Park Group will construct the 550-bed facility on a 3.22-acre allotted site, located directly behind Arail Ghat in one of Prayagraj's most densely populated areas. Construction is targeted for completion within two years of the appointed date. The project is described in the filing as the third pillar of the group's Uttar Pradesh strategy.
The State Government's reimbursement of INR 76.52 crore toward construction costs de-risks a significant portion of the capital outlay. In return, Park Group will pay an annual concession fee of INR 18.10 crore with 3% annual escalation over the 45-year lease. The company states that its share of investment will be funded through internal accruals. Upon completion, the Prayagraj hospital, combined with the group's 360-bed facility at Agra and its upcoming 400-bed unit at Gorakhpur, will bring Park Group's total Uttar Pradesh capacity to approximately 1,260 beds.
Impact on Investors
Investors will note that the disclosed funding mode, internal accruals, implies no equity dilution or announced debt raise linked to this project at this stage. The filing shows that state government support of INR 76.52 crore materially reduces the net capital requirement for the company on this project.
Shareholders will observe that this is a board-approved capacity addition at an early construction stage, with the 45-year concession providing long-term revenue visibility once the facility reaches commercial operations. The two-year construction period and the concession fee obligation of INR 18.10 crore per annum with annual escalation are cost commitments that investors should weigh against the group's current financial position as disclosed in its filings.
Sector / Market Context
Uttar Pradesh, India's most populous state, has hospital bed density materially below both the national average and the WHO benchmark of 3 beds per 1,000 population, creating a structural supply gap. The Indian government's push for PPP-based healthcare infrastructure, supported by state-level concession frameworks, has been a noted policy lever for expanding tertiary care capacity in under-served regions.